08 April 2016 : Review article
Eluxadoline: A New FDA-Approved Treatment for Irritable Bowel Syndrome with DiarrheaIhsan Al-BayatiABEF, Mohamed TelebBF, Marc J. ZuckermanAE
Med Sci Rev 2016; 3:45-48
Irritable bowel syndrome (IBS) is characterized by chronic, recurrent abdominal pain with altered bowel habits, in the absence of organic disease, with episodes lasting for at least 3 months. Despite many treatment approaches to control symptoms, including dietary modification, newer agents that affect serotonin receptors, and antibiotics, cases that are refractory to these treatments persist and are associated with many functionally and socially disabling symptoms that can have a negative impact on the patient’s quality of life. This article provides an update on a new medication, eluxadoline, for IBS with diarrhea, recently approved by the US Food and Drug Administration. As a µ- and κ-opioid receptor agonist and a δ-opioid receptor antagonist, eluxadoline showed efficacy in animal studies in controlling abdominal pain with fewer side effects of constipation and analgesic tolerance. Its efficacy and safety have been determined in phase 3 trials. Sphincter of Oddi spasm and pancreatitis are serious observed side effects in patients with no gallbladder, and avoidance of this medication in this patient population is advised.
Keywords: diarrhea, irritable bowel syndrome, Receptors, Opioid, delta
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952